Cross Country Healthcare Ends Merger with Aya Holdings; Aya to Pay $20 Million Penalty
Merger Termination: Cross Country Healthcare (CCRN) has terminated its merger agreement with Aya Holdings due to the inability to extend the deal beyond the December 3, 2025, deadline, resulting in a $20 million termination fee owed by Aya to Cross Country.
Regulatory Delays: The merger faced delays from an FTC Hart-Scott-Rodino review, exacerbated by a historic government shutdown, which pushed the review's end date past the merger's termination date.
Market Impact: Following the announcement of the merger's termination, CCRN shares dropped by 19.6%.
Company Performance: Cross Country Healthcare has missed financial estimates and canceled its earnings call while suspending guidance due to the pending transaction.
Trade with 70% Backtested Accuracy
Analyst Views on CCRN
About CCRN
About the author

- Community Partnership: Cross Country Healthcare has announced a new partnership with South Florida nonprofit Open Hearts for Orphans, aimed at supporting orphaned and vulnerable children through community engagement and employee involvement, reflecting a shared mission to improve family and community outcomes.
- Mission-Driven Collaboration: This partnership emphasizes the importance of supporting vulnerable children and strengthens the commitment of both organizations to provide care and hope, with a goal of creating measurable impact for children and families through strategic initiatives.
- Employee Engagement Opportunities: Cross Country Healthcare will promote long-term collaboration with OHFO through employee engagement opportunities and awareness-building activities, further enhancing community support to ensure that orphaned and vulnerable children receive the necessary care and stability.
- Tech-Driven Solutions: Cross Country Healthcare leverages its AI-powered digital platform and advisory services to optimize healthcare workforce ecosystems, ensuring that while supporting vulnerable children, the overall quality and efficiency of care are also improved.
- Earnings Miss: Cross Country Healthcare reported a Q4 non-GAAP EPS of -$0.06, missing expectations by $0.09, indicating significant challenges in profitability that could undermine investor confidence.
- Revenue Decline: The company’s Q4 revenue of $236.8M represents a 23.6% year-over-year decline, falling short by $17.5M, reflecting weak market demand and intensified competition, which may hinder future growth prospects.
- Future Guidance: Management's guidance for Q1 2026 revenue is set at $235M to $240M, projecting a year-over-year decline of 20% to 18%, indicating a lack of confidence in short-term recovery, which could affect shareholder investment decisions.
- Adjusted EBITDA Outlook: The expected adjusted EBITDA range of $4.0M to $5.0M reflects a year-over-year decline of 54% to 42%, highlighting significant challenges in cost control and operational efficiency that may impact the company’s competitive position in the market.
- Earnings Announcement Date: Cross Country Healthcare (CCRN) is set to release its Q4 2023 earnings on March 4th after market close, with consensus EPS estimate at $0.03, reflecting a 25% year-over-year decline, and revenue expected at $254.3 million, down 17.9% year-over-year, indicating significant challenges ahead for the company.
- Historical Performance Review: Over the past two years, CCRN has beaten EPS estimates 50% of the time and revenue estimates 63% of the time, suggesting a degree of capability to exceed expectations, yet the recent downward revisions may undermine investor confidence.
- Expectation Revision Trends: In the last three months, EPS estimates have seen one upward revision and three downward revisions, while revenue estimates have experienced no upward revisions and four downward revisions, reflecting a cautious market outlook that could lead to stock price volatility.
- Merger Termination Impact: CCRN recently terminated its merger with Aya Holdings, which will incur a $20 million fee, and while this decision may negatively impact stock prices in the short term, it also provides the company with greater flexibility for future independent growth.
- Earnings Call Scheduled: Cross Country Healthcare will hold a conference call on March 4, 2026, at 5:00 PM ET to discuss its Q4 and full-year 2025 financial results, with the earnings press release set to be distributed after market close, aiming to keep investors informed of the latest financial performance.
- Live Webcast and Replay: The call will be webcast live on the company's website, with participants able to dial in at 800-369-2163 (U.S.) or 773-756-4715 (non-U.S.), and a replay will be available from March 4 to March 18, ensuring that investors who cannot attend live can still access critical information.
- Intellify® Platform Overview: Cross Country Healthcare leverages its Intellify® platform, a cloud-based workforce management and vendor management system, to help healthcare organizations optimize their labor ecosystem, improve resource utilization, and reduce complexity, thereby maintaining a competitive edge in the healthcare industry.
- Company Background and Vision: As a technology-driven company with nearly 40 years of healthcare labor expertise, Cross Country Healthcare aims to help health systems achieve sustainable labor optimization through AI-powered digital platforms and advisory services, enhancing service quality and operational efficiency.

Leadership Change: John Martins has resigned as President and CEO of Cross Country Healthcare, effective December 14, with Kevin Clark appointed as his successor.
Experience of New CEO: Kevin Clark, who co-founded the company and has nearly 40 years of experience in the healthcare staffing industry, will also continue as Chairman of the Board.
Market Reaction: Following the announcement, Cross Country Healthcare's stock rose by 4.83% to $8.90 in pre-market trading on the Nasdaq.
Disclaimer: The views expressed in the article are those of the author and do not necessarily reflect the opinions of Nasdaq, Inc.






